Effect of Bamlanivimab as Monotherapy or in Combination With

This randomized clinical trial compares the effects of 3 doses of bamlanivimab monotherapy (700 vs 2800 vs 7000 mg) vs combination bamlanivimab and etesevimab v

Related Keywords

Canada , Delaware , United States , Shawa , Shanxi , China , Helsinki , Eteläuomen Läi , Finland , America , Chinese , Junshi Biosciences , Bristol Myers Squibb , Danielm Skovronsky , Eli Lilly , Monte Carlo , Van Naarden , David Mcilwain , Abcellera Biologics , Morris , Pfizer , Drug Administration , Johnson , Institute Inc , World Health Organization , Infectious Diseases Vaccine Research Center , Amgen , Gilead Sciences , Glaxosmithkline , National Institute Of Allergy , Emergency Use , North America , Blocking Viral Attachment , Cell Entry , International Conference , Harmonization Guidelines , Good Clinical Practice , Secondary Outcomes , Enterprise Guide , Clinical Characteristics , Hoc Analyses , Emergency Use Authorization , Drs Gottlieb , Interest Disclosures , Drs Nirula , Drs Oakley , Sharing Statement , National Institute , Infectious Diseases Vaccine Research , Chinese Academy ,